Publications by authors named "H L Bullifent"

The highly virulent intracellular pathogen is a Gram-negative bacterium that has a wide host range, including humans, and is the causative agent of tularemia. To identify new therapeutic drug targets and vaccine candidates and investigate the genetic basis of virulence in the Fischer 344 rat, we have constructed an Schu S4 transposon library. This library consists of more than 300,000 unique transposon mutants and represents a transposon insertion for every 6 bp of the genome.

View Article and Find Full Text PDF

Background: The World Health Organization has categorized plague as a re-emerging disease and the potential for Yersinia pestis to also be used as a bioweapon makes the identification of new drug targets against this pathogen a priority. Environmental temperature is a key signal which regulates virulence of the bacterium. The bacterium normally grows outside the human host at 28 °C.

View Article and Find Full Text PDF

Massively parallel sequencing technology coupled with saturation mutagenesis has provided new and global insights into gene functions and roles. At a simplistic level, the frequency of mutations within genes can indicate the degree of essentiality. However, this approach neglects to take account of the positional significance of mutations - the function of a gene is less likely to be disrupted by a mutation close to the distal ends.

View Article and Find Full Text PDF

Yersinia pestis, a Gram negative bacterium, causes bubonic and pneumonic plague. Emerging antibiotic resistance in clinical isolates is driving a need to develop novel antibiotics to treat infection by this transmissible and highly virulent pathogen. Proteins required for viability, so called essential genes, are attractive potential therapeutic targets, however, confirmation of essentiality is problematic.

View Article and Find Full Text PDF
Article Synopsis
  • The emergence of antibiotic-resistant bacteria has created an urgent need for new antibiotics, particularly against dangerous pathogens like Yersinia pestis, which causes plague.
  • A previous study using bioinformatics identified CMP kinase as a potential target for antimicrobial therapy, initially thought to be essential for Yersinia pseudotuberculosis.
  • New research developed a mutant strain lacking CMP kinase (Δcmk), revealing its growth defects and reduced virulence in mice, while also detailing the enzyme’s structure to guide the creation of new CMP kinase inhibitors.
View Article and Find Full Text PDF